9 results
-
MSAC Consultation Survey - Application 1804
MSAC application 1804 - Genetic testing to detect RET variants in patients with medullary thyroid cancer to determine eligibility for PBS subsidised selpercatinib treatment. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed... MoreCloses 11 July 2025 -
MSAC Consultation Survey - Application 1803
MSAC application 1803 - Implantation of an active middle ear implant (Vibroplasty) for treatment of mixed and conductive hearing loss. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the... MoreCloses 11 July 2025 -
MSAC Consultation Survey - Application 1802
MSAC application 1802 - Supervised oral food challenge (OFC) in patients with suspected food allergy. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care ... MoreCloses 11 July 2025 -
MSAC Consultation Survey - Application 1805
MSAC application 1805 - Concizumab for routine prophylaxis to prevent bleeding in patients with haemophilia B. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care ... MoreCloses 11 July 2025 -
MSAC Consultation Survey - Application 1806
MSAC application 1806 - Marstacimab for routine prophylaxis to prevent bleeding in patients with haemophilia. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care ... MoreCloses 11 July 2025 -
REGISTER for "Consumer Inputs for HTA Committees' considerations" Consumer Webinar, 23 July 2025
The Chair of the Health Technology Assessment (HTA) Consumer Consultative Committee (CCC), Adjunct Associate Professor Jo Watson, invites health consumers and health consumer organisations to a free webinar: "Enhancing HTA - Consumer Inputs for HTA Committees' considerations" HTA Committees include the Pharmaceutical Benefits Advisory Committee (PBAC) and the Medical Services Advisory Committee (MSAC). 11:00am – 12:30pm (AEST), Wednesday 23 July 2025 ... MoreCloses 18 July 2025 -
CEEU/HTA Updates
Receive regular HTA Engage e-newsletters for updates on HTA activities and announcements from the CEEU, including open consultation dates for PBAC and MSAC meeting agenda items. MoreCloses 1 June 2028 -
MSAC Updates
Subscribe to MSAC email bulletins on the MSAC meeting agendas and consultations, and important updates. MoreCloses 1 June 2028 -
PBAC Updates
Subscribe to PBS.gov.au email notification of the Pharmaceutical Benefits Scheme (PBS) news, including PBAC meeting agendas, consultations and outcomes. MoreCloses 1 June 2028
9 results.
Page 1 of 1